SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021) (vol 24, pg 712, 2022)
Por:
Majem, M, de las Penas, R, Virizuela, JA, Cabezon-Gutierrez, L, Cruz, P, Lopez-Castro, R, Mendez, M, Mondejar, R, Munoz, MD, Escobar, Y
Publicada:
1 jul 2022
Ahead of Print:
1 may 2022
Resumen:
In this article the title was incorrectly given as “SEOM clinical guideline emesis (2021)” but should have been “SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2021).” The original article has been corrected. © 2022, The Author(s).
Filiaciones:
Majem, M:
Hosp Santa Creu & Sant Pau, Dept Med Oncol, C St Antoni Maria Claret 167, Barcelona 08025, Spain
de las Penas, R:
Hosp Prov Castello, Dept Med Oncol, Valencia, Spain
Virizuela, JA:
Hosp Univ Virgen Macarena, Dept Med Oncol, Seville, Spain
Cabezon-Gutierrez, L:
Hosp Univ Torrejon, Dept Med Oncol, Madrid, Spain
Cruz, P:
Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain
Lopez-Castro, R:
Univ Valladolid, Dept Med Oncol, Hosp Clin, Valladolid, Spain
Mendez, M:
Hosp Univ Puerta Hierro Majadahonda, Dept Med Oncol, Madrid, Spain
Mondejar, R:
Hosp Univ La Princesa, Dept Med Oncol, Madrid, Spain
Munoz, MD:
Hosp Virgen Luz Cuenca, Dept Med Oncol, Cuenca, Spain
Escobar, Y:
Hosp Gen Univ Gregorio Maranon, Dept Med Oncol, Madrid, Spain
hybrid, Hybrid Gold
|